Loading...
XT logo

iShares Trust - iShares Future Exponential Technologies ETFNasdaqGM:XT 株式レポート

時価総額 US$3.9b
株価
US$82.28
私の公正価値
n/a
1Y30.8%
7D2.3%
1D
ポートフォリオ価値
​
表示

iShares Trust - iShares Future Exponential Technologies ETF

NasdaqGM:XT 株式レポート

時価総額：US$3.9b

iShares Trust - iShares Future Exponential Technologies ETF（XT）株式概要

iシェアーズ・トラスト - iシェアーズ・フューチャー・エクスポネンシャル・テクノロジーズETFは、ブラックロック社が設定した上場投資信託です。 詳細

XT ファンダメンタル分析
スノーフレーク・スコア
評価0/6
将来の成長0/6
過去の実績0/6
財務の健全性0/6
配当金2/6

XT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

iShares Trust - iShares Future Exponential Technologies ETF 競合他社

 
 
 
 
 
 
 
 
 
 
 
 

価格と性能

株価の高値、安値、推移の概要iShares Trust - iShares Future Exponential Technologies ETF
過去の株価
現在の株価US$82.28
52週高値US$84.23
52週安値US$62.03
ベータ0
1ヶ月の変化3.99%
3ヶ月変化19.33%
1年変化30.79%
3年間の変化48.38%
5年間の変化31.94%
IPOからの変化219.53%

最新ニュース

Seeking Alpha • Apr 10

XT: More Sensitive Than General Market To Cost Of Capital Changes

Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

XT: An Undervalued Portfolio Of Innovative Global Tech Stocks

Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking Alpha
Seeking Alpha • Jun 07

XT Will Likely Continue Lagging The Broader IT Sector

Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking Alpha
Seeking Alpha • Mar 10

XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot

Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking Alpha
Seeking Alpha • Aug 07

XT: We're Going To Think Twice About This ETF

XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.

Recent updates

Seeking Alpha • Apr 10

XT: More Sensitive Than General Market To Cost Of Capital Changes

Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

XT: An Undervalued Portfolio Of Innovative Global Tech Stocks

Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking Alpha
Seeking Alpha • Jun 07

XT Will Likely Continue Lagging The Broader IT Sector

Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking Alpha
Seeking Alpha • Mar 10

XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot

Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking Alpha
Seeking Alpha • Aug 07

XT: We're Going To Think Twice About This ETF

XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.

株主還元

XTUS Capital MarketsUS 市場
7D2.3%4.1%2.2%
1Y30.8%12.4%24.8%

業界別リターン: XT過去 1 年間で12.4 % の収益を上げたUS Capital Markets業界を上回りました。

リターン対市場: XT過去 1 年間で24.8 % の収益を上げたUS市場を上回りました。

価格変動

Is XT's price volatile compared to industry and market?
XT volatility
XT Average Weekly Movement3.1%
Capital Markets Industry Average Movement3.5%
Market Average Movement7.2%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

安定した株価: XT 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。

時間の経過による変動: XTの 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO（最高経営責任者ウェブサイト
2015n/an/awww.ishares.com/us/products/272532/ishares-exponential-technologies-etf

iシェアーズ・トラスト - iシェアーズ・フューチャー・エクスポネンシャル・テクノロジーズETFは、ブラックロック社が設定した上場投資信託です。ファンドの運用はブラックロック・ファンド・アドバイザーズが行っている。当ファンドは、グローバル地域の公開株式市場に投資します。当ファンドは、情報技術セクターで事業を展開する企業の株式に投資する。多様な時価総額の企業のグロース株とバリュー株に投資します。当ファンドは、代表サンプリング手法を用いて、モーニングスター・エクスポネンシャル・テクノロジーズ・インデックスのパフォーマンスへの連動を目指します。 iシェアーズ・トラスト-iシェアーズ・フューチャー・エクスポネンシャル・テクノロジーズETFは、2015年3月19日に組成され、米国に籍を置いています。

iShares Trust - iShares Future Exponential Technologies ETF 基礎のまとめ

iShares Trust - iShares Future Exponential Technologies ETF の収益と売上を時価総額と比較するとどうか。
XT 基礎統計学
時価総額US$3.90b
収益（TTM）US$0
売上高(TTM)n/a
n/a
PER（株価収益率
n/a
P/Sレシオ

XT は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
XT 損益計算書（TTM）
収益US$0
売上原価US$0
売上総利益US$0
その他の費用US$0
収益US$0

直近の収益報告

該当なし

次回決算日

該当なし

一株当たり利益（EPS）0
グロス・マージン0.00%
純利益率0.00%
有利子負債／自己資本比率0.0%

XT の長期的なパフォーマンスは？

過去の実績と比較を見る

配当金

6.5%
現在の配当利回り
n/a
配当性向

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/06/16 08:48
終値2026/06/15 00:00
収益N/A
年間収益N/A

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

iShares Trust - iShares Future Exponential Technologies ETF 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0